The Power of Drug Discovery with Philip ...

<p>A labor and delivery nurse who ran Senate healthcare policy now manages $1.7 trillion in federal health spending—and she runs her team like a startup.</p><p>Steph Carlton, Chief of Staff and Deputy Administrator at CMS, reveals the OKRs driving Medicare and Medicaid, why they' ... Show More

<p>Drug discovery has doubled the flow of candidates, but approvals remain roughly flat. The constraint is development, not discovery. </p><p>In this episode, a16z General Partner, Jorge Conde talks with Formation Bio cofounder and CEO Ben Liu about building a modern pharma compa ... Show More

<p>Josh Weiner left Meta to return to CVS Health with two painful realizations: consumers don't manage their health—they expect it, and the healthcare market fundamentally violates every principle of economics. In this conversation with a16z's Julie Yoo, the CVS Senior VP explain ... Show More

<p>Today's guest is Emmanuel Walckenaer, CEO of YSEOP. YSEOP is a natural language generation AI vendor serving life sciences and drug development. In today's episode, Emmanuel speaks about speeding up the drug development process through the lens of the life sciences industry be ... Show More

<p>with Vas Narasimhan (@vasnarasimhan), Jorge Conde (@jorgecondebio), Vijay Pande (@vijaypande), and Sonal Chokshi (@smc90)</p><p>On average, only 1 out of 20 medicines works when we actually bring them into the human body, and these rates of success haven't moved much in the ph ... Show More

Today's guest is the great and brilliant Dr. Kristof Szalay, CTO and Founder of Turbine.AI. Turbine's AI-driven platform understands cancer's inner mechanisms, enabling the discovery of novel targets & precision medicinal therapies. Episode topics include: dynamics of pharmaceuti ... Show More

It may seem intuitive that AI and deep learning can speed up workflows — including novel drug discovery, a typically years-long and several-billion-dollar endeavor. But professors Artem Cherkasov and Olexandr Isayev were surprised to find that no recent academic papers provided a ... Show More

<p>In this episode of the AI Grand Rounds podcast, <a href='https://www.insitro.com/leadership/daphne-koller/'>Dr. Daphne Koller</a> charts her professional trajectory, tracing her early fascination with computers to her influential role in AI and health care. Initially intrigued ... Show More

<p>In this episode, <a href='https://dbmi.hms.harvard.edu/people/isaac-kohane'>Dr. Zak Kohane</a> shares his journey into AI and medicine, reflecting on early influences from science fiction authors and programming experiences in his youth. He discusses his academic path, moving ... Show More

<p>In this episode of the AI Grand Rounds podcast, <a href='https://profiles.stanford.edu/james-zou'>Dr. James Zou</a> shares his personal journey to discovering machine learning during his graduate studies at Harvard. Fascinated by the potential of AI and its application to geno ... Show More

<p>There's no question technology played a huge role in the recent/current pandemic, including especially in the <a href="https://a16z.com/2020/08/14/vaccines-vaccinology-renaissance-covid-pandemic-beyond/" target="_blank">plug-and-play</a> engineering and incredibly fast develop ... Show More

The potential of new AI tools is unarguable, but the fundamental question remains: How much do you trust AI? In this episode, which originally aired as part of our Top of Mind video series, Gartner Distinguished VP Analyst Mary Mesaglio explores both our trust and distrust of dig ... Show More